SHL Telemedicine Ltd. (SHLT)
Market Cap | 83.43M |
Revenue (ttm) | 57.08M |
Net Income (ttm) | -7.06M |
Shares Out | 16.39M |
EPS (ttm) | -0.54 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 354 |
Open | 5.09 |
Previous Close | 5.35 |
Day's Range | 5.09 - 5.31 |
52-Week Range | 4.06 - 12.00 |
Beta | 0.43 |
Analysts | Strong Buy |
Price Target | 11.00 (+107.16%) |
Earnings Date | Apr 17, 2024 |
About SHLT
SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio'B, a portable device to transmit a 12-lead ECG. The company also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monito... [Read more]
Financial Performance
In 2023, SHLT's revenue was $57.08 million, a decrease of -3.26% compared to the previous year's $59.00 million. Losses were -$7.06 million, 9184.2% more than in 2022.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for SHLT stock is "Strong Buy" and the 12-month stock price forecast is $11.0.
News
![](https://cdn.snapi.dev/images/v1/s/n/press2-2487502.jpg)
SHL Telemedicine Confirms Discussions Regarding a Possible Investment in its Israeli Activity
TEL AVIV & ZURICH & NEW YORK--(BUSINESS WIRE)---- $SHLT--SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine ...
![](https://cdn.snapi.dev/images/v1/c/0/press12-2440766.jpg)
SHL Telemedicine Expands Offering in Israel With Groundbreaking At-home Biomarker Blood Test
TEL AVIV, Israel & ZURICH & NEW YORK--(BUSINESS WIRE)---- $SHLT--SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telem...
![](https://cdn.snapi.dev/images/v1/s/d/press12-2433996.jpg)
SHL Telemedicine Announces Official Launch of SmartHeart® D2C Membership in the US Following Successful Soft Launch
TEL AVIV, Israel & ZURICH, & NEW YORK--(BUSINESS WIRE)---- $SHLT--SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal tele...
![](https://cdn.snapi.dev/images/v1/j/y/press4-2375181.jpg)
SHL Announces Full-Year 2023 Results - Stable Revenue Growth Alongside Groundbreaking Clinical Milestones
TEL AVIV, Israel & ZURICH & NEW YORK--(BUSINESS WIRE)---- $SHLT--SHL Telemedicine Ltd. (NASDAQ: SHLT; SIX Swiss Exchange: SHLTN) ("SHL" or the "Company"), a leading provider and developer of advanced ...
![](https://cdn.snapi.dev/images/v1/s/l/press7-2366556.jpg)
Imperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine's SmartHeart® in Post-ACS Patient Care
TEL AVIV & ZURICH & NEW YORK--(BUSINESS WIRE)---- $SHLT--SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine ...
![](https://cdn.snapi.dev/images/v1/f/s/press5-2360274.jpg)
SHL Telemedicine's SmartHeart® Technology Triumphs in US Army Project Convergence – Capstone 4 Experiment
TEL AVIV, Israel & ZURICH & NEW YORK--(BUSINESS WIRE)---- $SHLT--SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telem...
![](https://cdn.snapi.dev/images/v1/s/d/conf12-2357961.jpg)
SHL Telemedicine: Invitation to Conference Call Presenting Annual Results 2023
TEL AVIV, Israel & ZURICH & NEW YORK--(BUSINESS WIRE)---- $SHLT--SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN; NASDAQ: SHLT) ("SHL” or the “Company”), a leading provider and developer of advanced ...
![](https://cdn.snapi.dev/images/v1/4/w/press2-2324614.jpg)
SHL Telemedicine Receives Buy Rating with $11.00 Price Target
TEL AVIV, Israel & ZURICH & NEW YORK--(BUSINESS WIRE)---- $SHLT--SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telem...
![](https://cdn.snapi.dev/images/v1/j/o/press7-2254692.jpg)
Imperial College London TELE-ACS Clinical Trial Results, Using SHL Telemedicine's SmartHeart® Technology, to Be Presented at ACC 24
TEL AVIV, Israel & ZURICH & NEW YORK--(BUSINESS WIRE)---- $SHLT--SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telem...
![](https://cdn.snapi.dev/images/v1/0/z/press4-2201294.jpg)
SHL Telemedicine and BARMER to Highlight Digital Patient Care at BMC Congress 2024
TEL AVIV, Israel & ZURICH & NEW YORK--(BUSINESS WIRE)---- $SHLT--SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telem...
![](https://cdn.snapi.dev/images/v1/u/q/press10-2171651.jpg)
SHL Telemedicine Introduces SmartHeart® Direct-to-Consumer Membership Plan in the US
TEL AVIV & ZURICH & NEW YORK--(BUSINESS WIRE)---- $SHLT--SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL” or the “Company”), a leading provider and developer of advanced personal telemedicine ...
![](https://cdn.snapi.dev/images/v1/x/d/press4-2140889.jpg)
SHL Telemedicine Establishes US Nationwide Cardiology Network for ECG Interpretations and Telehealth Visits
TEL AVIV, Israel & ZURICH & NEW YORK--(BUSINESS WIRE)---- $SHLT--SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL” or the “Company”), a leading provider and developer of advanced personal telem...
![](https://cdn.snapi.dev/images/v1/k/6/press17-2114574.jpg)
SHL Telemedicine Announces Advancements in its Direct-to-Consumer Strategy in the US
TEL AVIV, Israel & ZURICH & NEW YORK--(BUSINESS WIRE)---- $SHLT--SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL” or the “Company”), a leading provider and developer of advanced personal telem...
![](https://cdn.snapi.dev/images/v1/g/z/press11-2077300.jpg)
SHL Telemedicine's SmartHeart® Technology Shows Remarkable Effects in Mayo Clinic and Imperial College London Trials
TEL AVIV, Israel & ZURICH & NEW YORK--(BUSINESS WIRE)---- $SHLT--SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL” or the “Company”), a leading provider and developer of advanced personal telem...
![](https://cdn.snapi.dev/images/v1/g/h/press20-2072481.jpg)
SHL Announces Half-Year Results 2023 – Strategic Moves to Accelerate Growth
TEL AVIV, Israel & ZURICH & NEW YORK--(BUSINESS WIRE)---- $SHLT--Regulatory News: SHL Telemedicine Ltd. (NASDAQ: SHLT; SIX Swiss Exchange: SHLTN) (“SHL” or the “Company”), a leading provider and devel...
![](https://cdn.snapi.dev/images/v1/g/7/press1-2056836.jpg)
SHL Telemedicine's SmartHeart® Technology to Take Center Stage at Upcoming VPM 2023 Conference
TEL AVIV, Israel & ZURICH & NEW YORK--(BUSINESS WIRE)---- $SHLT--SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL” or the “Company”), a leading provider and developer of advanced personal telem...
![](https://cdn.snapi.dev/images/v1/i/1/conf8-2051182.jpg)
SHL Telemedicine: Half-year results 2023 and Conference Call Scheduled for September 21, 2023
TEL AVIV, Israel, ZURICH and NEW YORK , Sept. 6, 2023 /PRNewswire/ -- SHL Telemedicine Ltd.
![](https://cdn.snapi.dev/images/v1/p/r/press7-1820820.jpg)
SHL Telemedicine to Commence Trading on NASDAQ Under the Symbol "SHLT"
Listing on the SIX Swiss Exchange to continue in parallel to the NASDAQ listing ZURICH and TEL AVIV , March 31, 2023 /PRNewswire/ -- SHL Telemedicine Ltd. ("SHL", SIX Swiss Exchange: SHLTN), a leading...